Company: TNRSF
Filing Date: 2025-10-30
Form Type: 6-K
Source: 0001171843-25-006840
Chunk: 9

Company: TENARIS SA
Filing Date: 2025-10-30
Form: 6-K
Chunk 9
---
,771 | ) |
| Net cash used in financing activities                                                        |                                            |            |                 (367,223 | ) |     |      | (318,371 | ) |     |            |              (1,597,296 | ) |     |      | (1,590,083 | ) |
| Decrease in cash and cash equivalents                                                        |                                            |            |                  (14,777 | ) |     |      | (176,041 | ) |     |            |                (101,315 | ) |     |      |   (923,785 | ) |
| Movement in cash and cash equivalents                                                        |                                            |            |                          |   |     |      |          |   |     |            |                         |   |     |      |            |   |
| At the beginning of the period                                                               |                                            |            |                  571,492 |   |     |      |  848,695 |   |     |            |                 660,798 |   |     |      |  1,616,597 |   |
| Effect of exchange rate changes                                                              |                                            |            |                   (9,754 | ) |     |      |    8,652 |   |     |            |                 (12,522 | ) |     |      |    (11,506 | ) |
| Decrease in cash and cash equivalents                                                        |                                            |            |                  (14,777 | ) |     |      | (176,041 | ) |     |            |                (101,315 | ) |     |      |   (923,785 | ) |
| At September 30,                                                                             |                                            |            |                  546,961 |   |     |      |  681,306 |   |     |            |                 546,961 |   |     |      |    681,306 |   |

Exhibit I – Alternative performance measures

Alternative performance measures should be considered in addition to, not as substitute for or superior to, other measures of financial performance prepared in accordance with IFRS.

EBITDA, Earnings before interest, tax, depreciation and amortization.

EBITDA provides an analysis of the operating results excluding depreciation and amortization and impairments, as they are recurring non-cash variables which can vary substantially from company to company depending on accounting policies and the accounting value of the assets. EBITDA is an approximation to pre-tax operating cash flow and reflects cash generation before working capital variation